Invenomic Capital Management’s PetMed Express PETS Stock Holding History

Invenomic Capital Management’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-97,934	Closed	-$325K	–	174
2025 Q2	$325K	Sell	97,934 -17,806	-15%	-$63.4K	0.02%	147
2025 Q1	$485K	Sell	115,740 -32,682	-22%	-$148K	0.02%	171
2024 Q4	$715K	Sell	148,422 -24,231	-14%	-$114K	0.03%	158
2024 Q3	$635K	Sell	172,653 -33,332	-16%	-$118K	0.03%	142
2024 Q2	$834K	Sell	205,985 -4,244	-2%	-$18.1K	0.04%	156
2024 Q1	$1.01M	Sell	210,229 -5,571	-3%	-$32.4K	0.05%	139
2023 Q4	$1.63M	Buy	+215,800	New	+$1.77M	0.07%	149

Other funds holding PETS

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Invenomic Capital Management's PETS Position: Q3 2025 in Review

Invenomic Capital Management sold out of PetMed Express (PETS) in Q3 2025, closing a stake of 97,934 shares — an estimated $325K sold.

Invenomic Capital Management first reported a position in PETS in Q4 2023 and held it in 7 quarters. The position peaked at $1.63M in Q4 2023. 59 funds tracked by Wall St. Rank hold PETS as of Q3 2025.

Invenomic Capital Management reported no remaining PetMed Express position as of Q3 2025 after selling out during the quarter.
Invenomic Capital Management sold 97,934 PetMed Express shares in Q3 2025, an estimated $325K.
Invenomic Capital Management first reported a position in PetMed Express in Q4 2023 and held it in 7 quarters.
Invenomic Capital Management's PetMed Express position peaked at $1.63M in Q4 2023.
59 funds tracked by Wall St. Rank held PetMed Express as of Q3 2025.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.